Allison Eddy
Last active: 2/3/2012

  1. Nephrotic syndrome in childhood. Eddy AA, Symons JM (2003) Lancet 362(9384): 629-39
    › Primary publication · 12944064 (PubMed)
  2. Plasminogen activator inhibitor-1 and the kidney. Eddy AA (2002) Am J Physiol Renal Physiol 283(2): F209-20
    › Primary publication · 12110504 (PubMed)
  3. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. Kim H, Oda T, López-Guisa J, Wing D, Edwards DR, Soloway PD, Eddy AA (2001) J Am Soc Nephrol 12(4): 736-48
    › Primary publication · 11274235 (PubMed)
  4. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Oda T, Jung YO, Kim HS, Cai X, López-Guisa JM, Ikeda Y, Eddy AA (2001) Kidney Int 60(2): 587-96
    › Primary publication · 11473641 (PubMed)
  5. Mast cells find their way to the kidney. Eddy AA (2001) Kidney Int 60(1): 375-7
    › Primary publication · 11422775 (PubMed)
  6. Molecular basis of renal fibrosis. Eddy AA (2000) Pediatr Nephrol 15(3-4): 290-301
    › Primary publication · 11149129 (PubMed)
  7. Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Eddy AA, Kim H, López-Guisa J, Oda T, Soloway PD (2000) Kidney Int 58(2): 618-28
    › Primary publication · 10916085 (PubMed)
  8. A morbid course in a girl with mixed connective tissue disease. Essalah AA, Eddy AA (1999) Pediatr Nephrol 13(1): 54-6
    › Primary publication · 10100290 (PubMed)
  9. The nephrotic syndrome: from the simple to the complex. Eddy AA, Schnaper HW (1998) Semin Nephrol 18(3): 304-16
    › Primary publication · 9613871 (PubMed)
  10. Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades. Eddy AA (1998) Kidney Int 53(5): 1182-9
    › Primary publication · 9573532 (PubMed)